BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16923021)

  • 21. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.
    Katakura S; Nagahara T; Hara T; Iwamoto M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.
    Peraramelli S; Suylen DP; Rosing J; Hackeng TM
    Thromb Haemost; 2012 Aug; 108(2):266-76. PubMed ID: 22627666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3,6-disubstituted coumarins as mechanism-based inhibitors of thrombin and factor Xa.
    Frédérick R; Robert S; Charlier C; de Ruyck J; Wouters J; Pirotte B; Masereel B; Pochet L
    J Med Chem; 2005 Dec; 48(24):7592-603. PubMed ID: 16302799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
    Stürzebecher J; Stürzebecher U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa.
    Ueno H; Katoh S; Yokota K; Hoshi J; Hayashi M; Uchida I; Aisaka K; Hase Y; Cho H
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4281-6. PubMed ID: 15261287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa.
    Thakur R; Kumar A; Bose B; Panda D; Saikia D; Chattopadhyay P; Mukherjee AK
    Biochimie; 2014 Oct; 105():149-58. PubMed ID: 25038567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational design, synthesis, and structure-activity relationships of novel factor Xa inhibitors: (2-substituted-4-amidinophenyl)pyruvic and -propionic acids.
    Sagi K; Nakagawa T; Yamanashi M; Makino S; Takahashi M; Takayanagi M; Takenaka K; Suzuki N; Oono S; Kataoka N; Ishikawa K; Shima S; Fukuda Y; Kayahara T; Takehana S; Shima Y; Tashiro K; Yamamoto H; Yoshimoto R; Iwata S; Tsuji T; Sakurai K; Shoji M
    J Med Chem; 2003 May; 46(10):1845-57. PubMed ID: 12723948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
    Bhongade BA; Gouripur VV; Gadad AK
    Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.
    Maignan S; Guilloteau JP; Choi-Sledeski YM; Becker MR; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2003 Feb; 46(5):685-90. PubMed ID: 12593649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors.
    Varnes JG; Wacker DA; Pinto DJ; Orwat MJ; Theroff JP; Wells B; Galemo RA; Luettgen JM; Knabb RM; Bai S; He K; Lam PY; Wexler RR
    Bioorg Med Chem Lett; 2008 Jan; 18(2):749-54. PubMed ID: 18054227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The discovery of glycine and related amino acid-based factor Xa inhibitors.
    Kohrt JT; Filipski KJ; Cody WL; Bigge CF; La F; Welch K; Dahring T; Bryant JW; Leonard D; Bolton G; Narasimhan L; Zhang E; Peterson JT; Haarer S; Sahasrabudhe V; Janiczek N; Desiraju S; Hena M; Fiakpui C; Saraswat N; Sharma R; Sun S; Maiti SN; Leadley R; Edmunds JJ
    Bioorg Med Chem; 2006 Jul; 14(13):4379-92. PubMed ID: 16529937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three recombinant serine proteinase inhibitors expressed from the coding region of the thrombin inhibitor dipetalogastin.
    Mende K; Lange U; Nowak G
    Insect Biochem Mol Biol; 2004 Sep; 34(9):971-9. PubMed ID: 15350616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biarylmethoxy isonipecotanilides as potent and selective inhibitors of blood coagulation factor Xa.
    Lopopolo G; Fiorella F; de Candia M; Nicolotti O; Martel S; Carrupt PA; Altomare C
    Eur J Pharm Sci; 2011 Feb; 42(3):180-91. PubMed ID: 21112391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization.
    Choi-Sledeski YM; McGarry DG; Green DM; Mason HJ; Becker MR; Davis RS; Ewing WR; Dankulich WP; Manetta VE; Morris RL; Spada AP; Cheney DL; Brown KD; Colussi DJ; Chu V; Heran CL; Morgan SR; Bentley RG; Leadley RJ; Maignan S; Guilloteau JP; Dunwiddie CT; Pauls HW
    J Med Chem; 1999 Sep; 42(18):3572-87. PubMed ID: 10479289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors.
    Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Uchida I; Aisaka K; Hase Y; Katoh S; Cho H
    Bioorg Med Chem Lett; 2005 Jan; 15(1):185-9. PubMed ID: 15582437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of structural information in the discovery of direct thrombin and factor Xa inhibitors.
    Nar H
    Trends Pharmacol Sci; 2012 May; 33(5):279-88. PubMed ID: 22503439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological activity of novel factor Xa inhibitors: improving metabolic stability by S1 and S4 ligand modification.
    Komoriya S; Kobayashi S; Osanai K; Yoshino T; Nagata T; Haginoya N; Nakamoto Y; Mochizuki A; Nagahara T; Suzuki M; Shimada T; Watanabe K; Isobe Y; Furugoori T
    Bioorg Med Chem; 2006 Mar; 14(5):1309-30. PubMed ID: 16263291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.